What does Amphastar Pharmaceuticals, Inc. (AMPH) do?

Amphastar Pharmaceuticals, Inc. (AMPH) is a publicly traded company in the Healthcare sector.

What sector does AMPH operate in?

Amphastar Pharmaceuticals, Inc. operates in the Healthcare, specifically within the Pharmaceuticals industry. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find AMPH earnings analysis?

AlphaOS publishes an earnings intelligence page for Amphastar Pharmaceuticals, Inc. (AMPH) covering results, guidance context, and AI-assisted analysis. See /stocks/AMPH/earnings. Content is for research and education — not investment advice.

Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

AMPH

Amphastar Pharmaceuticals, Inc.

Healthcare · Pharmaceuticals

$27.39Sep 28, 2026

AI confidence 70% · refreshes every 15s during session

Investment Snapshot

Weak evidence · 1 source

Why it matters

Amphastar Pharmaceuticals, Inc. shows accelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue +5% YoY in Q2 FY2026.

TrajectoryAccelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

Revenue +5% YoY in Q2 FY2026

Pipeline evidence · 0d ago

AMPH's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on AMPH.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full AMPH earnings analysis

Reported figures for Amphastar Pharmaceuticals, Inc. — research only, not investment advice.

Revenue YoY: +5.4%
EPS YoY: +4.7%

Latest Intelligence

Updated September 29, 2026

What happened recently for Amphastar Pharmaceuticals, Inc. (AMPH) — events, not interpretation.

Event: Reported Q2 2026 revenue +5% YoY.
Also: Last session September 28, 2026 at $27.39.
Source: Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

Amphastar Pharmaceuticals, Inc. (AMPH)

Healthcare · Pharmaceuticals

Investment Snapshot above is the primary AlphaOS analysis for Amphastar Pharmaceuticals, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:: Healthcare
Industry:: Pharmaceuticals
Market cap:: $1.17B
Revenue:: $183.90M

AMPH earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Amphastar Pharmaceuticals, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Related & Connected

Pharmaceutical Preparations90% confidencerelated

Connected companies and research pages from the AlphaOS knowledge graph.